Bullish
$SLS $3.30 high in pre market, going long here at $2.88 on favorable news. Feb 14 (Reuters) - Sellas Life Sciences Group Inc <SLS.O>: * SELLAS LIFE SCIENCES PROVIDES REGULATORY UPDATE FOR NELIPEPIMUT-S (NPS) FOR TRIPLE NEGATIVE BREAST CANCER (TNBC) FOLLOWING FDA FEEDBACK * SELLAS LIFE SCIENCES GROUP INC - FINALIZED DESIGN AND PLAN FOR A PHASE 3 REGISTRATION-ENABLING STUDY OF NPS IN COMBINATION WITH TRASTUZUMAB
  • 5
  • 1